Olivieri, Ignazio <br/><br/>
Efficacy, safety and cost per responder of biologics in the treatment of non-radiographic axial spondyloarthritis.  [electronic resource] 

 -  Clinical and experimental rheumatology   
 - 935-940 p.  digital 
<br/><br/> Publication Type: Journal Article; Review; Systematic Review 
<br/><br/><label>ISSN: </label>0392-856X 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab--economics<br/>Biological Products--adverse effects<br/>Certolizumab Pegol--economics<br/>Cost-Benefit Analysis<br/>Drug Costs<br/>Etanercept--economics<br/>Humans<br/>Models, Economic<br/>Randomized Controlled Trials as Topic<br/>Recovery of Function<br/>Remission Induction<br/>Sacroiliac Joint--diagnostic imaging<br/>Spine--diagnostic imaging<br/>Spondylarthritis--diagnostic imaging<br/>Time Factors<br/>Treatment Outcome<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors